A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia Article

Full Text via DOI: 10.1038/s41408-021-00568-3 Web of Science: 000712956600001
Open Access International Collaboration

Cited authors

  • Zeidner JF, Lin TRL, Vigil CE, Fine G, Levy MY, Nazha A, Esteve J, Lee DIJ, Yee K, Dalovisio A, Wang EIS, Burgues JBM, Schriber J, Litzow MR, Frankfurt O, Del Castillo TB, Bhatt VR, Bhatnagar B, Mehta P, Dillon R, Vicente MV, Anthony S, Bearss D, Montesinos P, Smith BD

Publication date

  • 2021

Published in


International Standard Serial Number (ISSN)

  • 2044-5385

Number of pages

  • 5


  • 11


  • 10